The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
Open accessAbstract
Toll-like receptors (TLRs) are the basic signaling receptors of the innate immune system. They are activated by molecules associated with pathogens or injured host cells and tissue. TLR3 has been shown to respond to double stranded (ds) RNA, a replication intermediary for many viruses. Here we present evidence that heterologous RNA released from or associated with necrotic cells or generated by in vitro transcription also stimulates TLR3 and induces immune activation. To assess RNA-mediated TLR3 activation, human embryonic kidney 293 cells stably expressing TLR3 and containing a nuclear factor-kappaB-dependent luciferase reporter were generated. Exposing these cells to in vitro transcribed RNA resulted in a TLR3-dependent induction of luciferase activity and interleukin-8 secretion. Treatment with in vitro transcribed mRNA activated nuclear factor-kappaB via TLR3 through a process that was dose-dependent and involved tyrosine phosphorylation. Furthermore, in vitro transcribed natural or 2'-fluoro-substituted mRNA induced the expression of TLR3, interferon regulatory factor-1, tumor necrosis factor-alpha, and interleukin-1 receptor-associated kinase-M mRNA in human dendritic cells (DCs). DCs responded to mRNA treatment by expressing activation markers, and this maturation was inhibited by antagonistic TLR3-specific antibody. Endogenous RNA released from or associated with necrotic cells also stimulated DCs, leading to interferon-alpha secretion, which could be abolished by pretreatment of necrotic cells with RNase. These results demonstrate that RNA, likely through secondary structure, is a potent host-derived activator of TLR3. This finding has potential physiologic relevance because RNA escaping from damaged tissue or contained within endocytosed cells could serve as an endogenous ligand for TLR3 that induces or otherwise modulates immune responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“not only viral RNA, but also endogenous mRNA associated with apoptotic cells as well as in vitro transcribed (IVT) mRNA could bind and activate TLR3, TLR7 and TLR8 [4,5]”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [4]
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319
Flagged first, then by citations
2 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- Armant, 2002, Genome Biol.
- Barton, 2002, Curr. Top. Microbiol. Immunol., 270, 81
- Vabulas, 2002, Curr. Top. Microbiol. Immunol., 270, 169
- Grentzmann, 1998, RNA (N. Y.), 4, 479
- Williams, 2001, Science's STKE
- Kirschning, 2002, Curr. Top. Microbiol. Immunol., 270, 121
- Larsson, 2003, Curr. Top. Microbiol. Immunol., 276, 261
- Belz, 2002, Crit. Rev. Immunol., 22, 439
Cited by
Sorted by citations
Items 501–600 of 1,000
RNA-based therapy for osteogenesis
Wang, P., Perche, F., Logeart‐Avramoglou, D., & Pichon, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118594 · Cited by 38
Korzun, T., Moses, A. S., Diba, P., Sattler, A. L., Taratula, O. R., Sahay, G., Taratula, O., & Marks, D. L. (2023) · Pharmaceuticals · doi:10.3390/ph16081088 · Cited by 40
Ghosh, M., Schaefer, T. M., Fahey, J. V., Wright, J. A., & Wira, C. R. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.023 · Cited by 37
Toll-like Receptor-3 Stimulation Upregulates sFLT-1 Production by Trophoblast Cells
Nakada, E., Walley, K. R., Nakada, T., Hu, Y., von Dadelszen, P., & Boyd, J. H. (2009) · Placenta · doi:10.1016/j.placenta.2009.07.001 · Cited by 38
A TRIF-Independent Branch of TLR3 Signaling
Yamashita, M., Chattopadhyay, S., Fensterl, V., Zhang, Y., & Sen, G. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103220 · Cited by 38
Bhargavan, B., Woollard, S. M., & Kanmogne, G. D. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.11.005 · Cited by 38
Kosik-Bogacka, D. I., Wojtkowiak‐Giera, A., Kolasa, A., Sałamatin, R., Jagodziński, P. P., & Wandurska-Nowak, E. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.12.002 · Cited by 36
Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation
Kis‐Tóth, K., & Tsokos, G. C. (2010) · Autoimmunity · doi:10.3109/08916930903214041 · Cited by 36
Gillespie, M. A. K., Gold, E. S., Ramsey, S. A., Podolsky, I., Aderem, A. A., & Ranish, J. A. (2015) · The EMBO Journal · doi:10.15252/embj.201489819 · Cited by 36
Toll-like receptor 3 modulates the behavioral effects of cocaine in mice
Zhu, R., Bu, Q., Fu, D., Shao, X., Jiang, L., Guo, W., Chen, B., Liu, B., Hu, Z., Tian, J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1130-8 · Cited by 36
Ranjith-Kumar, C. T., Duffy, K. E., Jordan, J. L., Bassiri, A. E., Vaughan, R. C., Hoose, S. A., Lamb, R. J., Sarisky, R. T., & Kao, C. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00308-08 · Cited by 36
Kooijman, S., Brummelman, J., van Els, C. A. C. M., Marino, F., Heck, A. J. R., Mommen, G. P. M., Metz, B., Kersten, G. F. A., Pennings, J. L. A., & Meiring, H. D. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2017.12.021 · Cited by 36
Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth
Zapletal, E., Vasiljević, T., Busson, P., & Glavan, T. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065278 · Cited by 41
Novel immunotherapeutic options for BCG‐unresponsive high‐risk non‐muscle‐invasive bladder cancer
Hannouneh, Z. A., Hijazi, A., Alsaleem, A. A., Hami, S., Kheyrbek, N., Tanous, F., Khaddour, K., Abbas, A., & Alshehabi, Z. (2023) · Cancer Medicine · doi:10.1002/cam4.6768 · Cited by 36
Cavassani, K. A., Serezani, A. P. M., Habiel, D. M., Ito, T., Coelho, A. L., Allen, R., Hu, B., Raphelson, J. R., Carson, W. F., Schaller, M. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065899 · Cited by 35
Ahmad, U., Ali, R., Lebastchi, A. H., Qin, L., Lo, S.-F. L., Yakimov, A. O., Khan, S. F., Choy, J. C., Geirsson, A., Pober, J. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902283 · Cited by 36
Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
Baidya, R., Crawford, D. H., Gautheron, J., Wang, H., & Bridle, K. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165931 · Cited by 41
Cytidine Acetylation Yields a Noninflammatory Synthetic Messenger RNA
Nance, K. D., Gamage, S. T., Alam, M. M., Yang, A., Levy, M. J., Link, C. N., Florens, L. A., Washburn, M. P., Gu, S., Oppenheim, J. J., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.07.003 · Cited by 35
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration
Kunze, R., Fischer, S., Marti, H. H., & Preissner, K. T. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00954-y · Cited by 37
Short Double-Stranded RNA with Immunostimulatory Activity: Sequence Dependence
Kabilova, T. O., Meschaninova, M. I., Venyaminova, A. G., Nikolin, V. P., Аркадьевна, З. М., Vlassov, V. V., & Chernolovskaya, E. L. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0328 · Cited by 35
Nucleic Acid Recognition Receptors in Autoimmunity
Krug, A. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_7 · Cited by 35
Gooshe, M., Abdolghaffari, A. H., Gambuzza, M. E., & Rezaei, N. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0026 · Cited by 36
The molecular structure of the TLR3 extracellular domain
Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Davies, D. R., & Segal, D. M. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120060801 · Cited by 35
Melhem, N. M., Liu, X. D., Boczkowski, D., Gilboa, E., & Barratt‐Boyes, S. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636782 · Cited by 34
Primary sterile necrotic cells fail to cross-prime CD8+T cells
Gamrekelashvili, J., Ormandy, L. A., Heimesaat, M. M., Kirschning, C. J., Manns, M. P., Korangy, F., & Greten, T. F. (2012) · OncoImmunology · doi:10.4161/onci.21098 · Cited by 36
The role of Toll-like receptors (TLRs) in stroke
Fadakar, K., Dadkhahfar, S., Esmaeili, A., & Rezaei, N. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0069 · Cited by 33
Hatterer, E., Shang, L., Simonet, P., Herren, S., Daubeuf, B., Teixeira, S., Reilly, J. H., Elson, G., Nelson, R., Gabay, C., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1128-5 · Cited by 34
Cow milk exosomes activate NK cells and γδT cells in human PBMCs in vitro
Komine‐Aizawa, S., Ito, S., Aizawa, S., Namiki, T., & Hayakawa, S. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1791400 · Cited by 34
Synthesis of point-modified mRNA
Hertler, J., Slama, K., Schober, B., Özrendeci, Z., Marchand, V., Motorin, Y., & Helm, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac719 · Cited by 35
Pattern recognition receptors in microbial keratitis
Taube, M.-A., Cendra, M. D. M., Elsahn, A. F., Christodoulides, M., & Hossain, P. N. (2015) · Eye · doi:10.1038/eye.2015.118 · Cited by 34
Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?
Yu, L., Wang, L., & Chen, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0864-6 · Cited by 34
Lichtnekert, J., Vielhauer, V., Zecher, D., Kulkarni, O. P., Clauß, S., Segerer, S., Hornung, V., Mayadas, T. N., Beutler, B., Akira, S., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90213.2008 · Cited by 34
Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
Gollmann‐Tepeköylü, C., Graber, M., Hirsch, J., Mair, S., Naschberger, A., Pölzl, L., Nägele, F., Kirchmair, E., Degenhart, G., Demetz, E., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.063481 · Cited by 35
Ballak, D. B., van Asseldonk, E. J. P., van Diepen, J. A., Jansen, H. J., Hijmans, A., Joosten, L. A. B., Tack, C. J., Netea, M. G., & Stienstra, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123152 · Cited by 33
RNA pulsed dendritic cells: An approach for cancer immunotherapy
Garg, N. K., Dwivedi, P., Prabha, P. S., & Tyagi, R. K. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.027 · Cited by 35
Sensing herpes: more than toll
Melchjorsen, J. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.716 · Cited by 33
Zhang, W., Liu, Y., Chin, J. M., & Phua, K. K. L. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.011 · Cited by 33
Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
Abbasi, S., & Uchida, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050644 · Cited by 33
Human proximal tubule epithelial cells modulate autologous dendritic cell function
Kassianos, A. J., Sampangi, S., Wang, X., Roper, K. E., Beagley, K. W., Healy, H. G., & Wilkinson, R. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs136 · Cited by 33
Nakamura, M., Funami, K., Komori, A., Yokoyama, T., Aiba, Y., Araki, A., Takii, Y., Ito, M., Matsuyama, M. M., Koyabu, M., et al. (2008) · Hepatology International · doi:10.1007/s12072-008-9055-4 · Cited by 33
Karpus, O. N., Heutinck, K. M., Wijnker, P. J. M., Tak, P. P., & Hamann, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035606 · Cited by 33
Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes
Djafarzadeh, S., Vuda, M., Takala, J. A., Ochs, M., & Jakob, S. M. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.07.010 · Cited by 33
Morzaev, D., Nicholson, J. D., Caspi, T., Weiss, S., Hochhauser, E., & Goldenberg‐Cohen, N. (2015) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12521 · Cited by 33
Wang, Z., Li, X., Shao, J., & Yuan, Z. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00019-06 · Cited by 34
Chun, C. D., Liles, W. C., Frevert, C. W., Glenny, R. W., & Altemeier, W. A. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-57 · Cited by 35
Suresh, M. V., Thomas, B., Machado-Aranda, D., Dolgachev, V. A., Ramakrishnan, S. K., Talarico, N. E., Cavassani, K. A., Sherman, M. A., Hemmila, M. R., Kunkel, S. L., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001879 · Cited by 33
Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington’s disease mice
Griffioen, K. J. S., Mattson, M. P., & Okun, E. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00508 · Cited by 33
Knockout of toll-like receptor impairs nerve regeneration after a crush injury
Hsieh, C., Rau, C., Kuo, P., Liu, S., Wu, C., Lu, T., Wu, Y.-C., & Lin, C.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.20206 · Cited by 32
Toll-like receptor 4 in pancreatic damage and immune infiltration in acute pancreatitis
MATTKE, J. D., Darden, C. M., Lawrence, M. C., Kuncha, J., Shah, Y. A., Kane, R. R., & Naziruddin, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362727 · Cited by 34
HIV infection suppresses TLR3 activation‐mediated antiviral immunity in microglia and macrophages
Liu, H., Zhou, R., Liu, Y., Guo, L., Wang, X., Hu, W., & Ho, W. (2020) · Immunology · doi:10.1111/imm.13181 · Cited by 32
Berdis, A. J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1051525 · Cited by 31
He, Q., Graham, C. S., Durante‐Mangoni, E., & Koziel, M. J. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01357.x · Cited by 32
Fabre, O., Breuker, C., Amouzou, C., Salehzada, T., Kitzmann, M., Mercier, J. G., & Bisbal, C. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.104 · Cited by 33
Viral Double-Strand RNA-Binding Proteins Can Enhance Innate Immune Signaling by Toll-Like Receptor 3
Lai, Y. Y., Yi, G., Chen, A. P., Bhardwaj, K., Tragesser, B. J., Valverde, R. A., Zlotnick, A., Mukhopadhyay, S., Ranjith-Kumar, C. T., & Kao, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025837 · Cited by 32
Veyrat, M., Durand, S., Classe, M., Glavan, T. M., Oker, N., Kapetanakis, N.-I., Jiang, X., Gelin, A., Herman, P., Casiraghi, O., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12892 · Cited by 32
In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity
Loomis, K. H., Lindsay, K. E., Zurla, C., Bhosle, S. M., Vanover, D. A., Blanchard, E. L., Kirschman, J. L., Bellamkonda, R. V., & Santangelo, P. J. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00443 · Cited by 32
Microbial nucleic acids pay a Toll in kidney disease
Pawar, R. D., Patole, P. S., Wörnle, M., & Anders, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00453.2005 · Cited by 32
Cavac, E., Ramírez-Tapia, L. E., & Martin, C. T. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100999 · Cited by 31
Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
Kim, H., Kirtane, A. R., Kim, N. Y., Rajesh, N. U., Tang, C., Ishida, K., Hayward, A. M., Langer, R., & Traverso, G. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00844-z · Cited by 31
RNA Therapeutics: Delivery Problems and Solutions—A Review
Pozdniakova, N. V., Generalov, E. A., Shevelev, A. B., & Tarasova, O. A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101305 · Cited by 37
Bhagwani, A. R., Thompson, A. A. R., & Farkas, L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00352 · Cited by 32
Sîrbulescu, R. F., Mamidi, A., Chan, S. C., Jin, G., Boukhali, M., Sobell, D., Ilieş, I., Chung, J. Y., Haas, W., Whalen, M. J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101095rr · Cited by 31
Innate immune system activation in zebrafish and cellular models of Diamond Blackfan Anemia
Danilova, N., Wilkes, M. C., Бибикова, Е., Youn, M., Sakamoto, K. M., & Lin, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-23561-6 · Cited by 32
Vontell, R., Supramaniam, V. G., Wyatt‐Ashmead, J., Gressèns, P., Rutherford, M., Hagberg, H., & Thornton, C. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000172 · Cited by 30
Gao, Y., Fang, X., Sun, H., Wang, Y., Yao, L., Li, J. P., Tong, Y. A., Zhang, B., & Liu, Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1665 · Cited by 30
New frontiers in precision medicine for Sjogren’s syndrome
Chatzis, L., Vlachoyiannopoulos, P. G., Tzioufas, A. G., & Goules, A. V. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1879641 · Cited by 32
Expression of Toll-like Receptors in Genital Tract Tissues from Normal and HIV-infected Men
Pudney, J. A., & Anderson, D. J. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00877.x · Cited by 30
A novel protective role for the innate immunity Toll-Like Receptor 3 (TLR3) in the retina via Stat3
Patel, A. K., & Hackam, A. S. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.09.004 · Cited by 30
Hara, Y., Shiraishi, A., Kobayashi, T., Kadota, Y., Shirakata, Y., Hashimoto, K., & Ohashi, Y. (2009) · PubMed Central · Cited by 30
Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes
Hermann, J. K., & Capadona, J. R. (2018) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2018027166 · Cited by 31
DNA double-strand break repair and nucleic acid-related immunity
Zhang, H., Chen, Y., Jiang, Y., & Mao, Z. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022061 · Cited by 28
MSCs and hyaluronan: Sticking together for new therapeutic potential?
Kota, D. J., Prabhakara, K. S., Cox, C. S., & Olson, S. D. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.07.022 · Cited by 29
Calvén, J., Yudina, Y., & Uller, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062718 · Cited by 30
Toll-Like Receptor 3: Involvement with Exogenous and Endogenous RNA
Amarante, M. K., & Watanabe, M. A. E. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.525723 · Cited by 29
Fan, L., Zhou, P., Qi, H., Chen, A.-X., Liu, G., Yu, K., & Shao, Z. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1593801 · Cited by 30
Comparative immunopathogenesis and biology of recently discovered porcine circoviruses
Rakibuzzaman, A., & Ramamoorthy, S. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14244 · Cited by 29
Burel, S. A., Machemer, T., Ragone, F. L., Kato, H., Cauntay, P., Greenlee, S., Salim, A., Gaarde, W. A., Hung, G., Peralta, R. Q., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193789 · Cited by 29
Toll-like receptors: a new target in rheumatoid arthritis?
Drexler, S. K., Sacre, S. M., & Foxwell, B. M. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.585 · Cited by 30
Bhargavan, B., & Kanmogne, G. D. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0816-8 · Cited by 29
Johnson, J., Albarani, V., Nguyen, M., Goldman, M., Willems, F., & Aksoy, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700421200 · Cited by 29
Mucins and Toll-like receptors: Kith and kin in infection and cancer
Tarang, S., Sushil Kumar, K., & Batra, S. K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.040 · Cited by 29
Franchini, M., Monnais, E., Seboek, D., Radimerski, T., Zini, E., Kaufmann, K., Lutz, T. A., Reusch, C. E., Ackermann, M., Müller-Stich, B. P., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1261872 · Cited by 28
Nucleic acid delivery and nanoparticle design for COVID vaccines
Andresen, J. L., & Fenton, O. S. (2021) · MRS Bulletin · doi:10.1557/s43577-021-00169-2 · Cited by 32
Epitranscriptomics of SARS-CoV-2 Infection
Izadpanah, A., Rappaport, J., & Datta, P. K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849298 · Cited by 28
Necrosis-induced TLR3 Activation Promotes TLR2 Expression in Gingival Cells
Mori, K., Yanagita, M., Hasegawa, S., Kubota, M., Yamashita, M., Yamada, S., Kitamura, M., & Murakami, S. (2015) · Journal of Dental Research · doi:10.1177/0022034515589289 · Cited by 28
Toll-like receptors in lymphoid malignancies: Double-edged sword
Harsini, S., Beigy, M., Sabagh, M. A., & Rezaei, N. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.08.010 · Cited by 27
Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus
Assmann, T. S., Brondani, L. D. A., Bouças, A. P., Canani, L. H. S., & Crispim, D. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000003 · Cited by 28
Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes
Borysiewicz, E., Fil, D., & Konat, G. W. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21968 · Cited by 28
Beyond TLR Signaling—The Role of SARM in Antiviral Immune Defense, Apoptosis & Development
Panneerselvam, P., & Ding, J. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1065826 · Cited by 28
Sköld, A. E., Hasan, M., Vargas, L., Saïdi, H., Dereuddre‐Bosquet, N., Grand, R. L., Smith, C. I. E., & Spetz, A. (2012) · Blood · doi:10.1182/blood-2011-12-397778 · Cited by 27
Damage-associated molecular patterns and their receptors in upper airway pathologies
Crombruggen, K. V., Jacob, F., Zhang, N., & Bachert, C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1356-7 · Cited by 27
Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer
Seya, T., Azuma, M., & Matsumoto, M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.765407 · Cited by 27
Bokarewa, M. I., Tarkowski, A., Lind, M., Dahlberg, L., & Magnusson, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838362 · Cited by 27
Lim, D. M., & Wang, M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00471.2010 · Cited by 27
Zandieh, Z., Amjadi, F., Ashrafi, M., D, A. A. M., Fazeli, A., & Aflatoonian, R. (2016) · PubMed Central · doi:10.22074/cellj.2016.3840 · Cited by 27
Adase, C. A., Borkowski, A. W., Zhang, L., Williams, M. R., Sato, E., Sanford, J. A., & Gallo, R. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725317 · Cited by 28
Down modulation of human TLR3 function by a monoclonal antibody
Duffy, K. E., Lamb, R. J., Mateo, L. R. S., Jordan, J. L., Canziani, G., Brigham-Burke, M. R., Korteweg, J., Cunningham, M., Beck, H., Carton, J. M., et al. (2007) · Cellular Immunology · doi:10.1016/j.cellimm.2007.10.002 · Cited by 27
Toll-like receptors and integrins crosstalk
Alhamdan, F., Bayarsaikhan, G., & Yuki, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403764 · Cited by 30
Baiersdörfer, M., Schwarz, M., Seehafer, K., Lehmann, C. H. K., Heit, A., Wagner, H., Kirschning, C. J., & Koch-Brandt, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.07.022 · Cited by 27
Itch Control by Toll-Like Receptors
Taves, S., & Ji, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_7 · Cited by 26
Metadata
- Authors
- Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D.
- Affiliations
- University of Pennsylvania (US)
- Eisai (United States) (US)
- Corresponding author
- Karikó, Katalin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 12542-12550
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986178107
- Cited by
- 1,062
- References
- 63
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 39 · 2023: 64 · 2022: 48 · 2021: 55 · 2020: 37 · 2019: 32 · 2018: 41 · 2017: 51 · 2016: 38 · 2015: 46 · 2014: 46 · 2013: 57 · 2012: 67
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl062060-05)
- National Heart, Lung, and Blood Institute (HL62060-04)
- National Institute of Allergy and Infectious Diseases (AI-50484, R01AI050484)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TLR3, mRNA, endogenous ligands, innate immunity, dendritic cell maturation, necrotic cells, double-stranded RNA, interferon-alpha, NF-κB, tyrosine phosphorylation, IRF1, TNF-α, RNA secondary structure
- MeSH terms
- Cell Line, Dendritic Cells, Dose-Response Relationship, Drug, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Humans, Ligands, Luciferases, Membrane Glycoproteins, Necrosis, Nucleic Acid Conformation, Plasmids, Protein Kinases, Receptors, Cell Surface, RNA, RNA, Double-Stranded, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Necrosis Factor-alpha, Tyrosine, Blotting, Northern, Signal Transduction, Up-Regulation, Interleukin-8, NF-kappa B, Staurosporine, Genistein, Toll-Like Receptors, Toll-Like Receptor 3, Interleukin-1 Receptor-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review